chr6-143941684-G-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001317162.2(PLAGL1):ā€‹c.1132C>Gā€‹(p.Leu378Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000033 ( 0 hom., cov: 32)
Exomes š‘“: 0.000020 ( 0 hom. )

Consequence

PLAGL1
NM_001317162.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.677
Variant links:
Genes affected
PLAGL1 (HGNC:9046): (PLAG1 like zinc finger 1) This gene encodes a C2H2 zinc finger protein that functions as a suppressor of cell growth. This gene is often deleted or methylated and silenced in cancer cells. In addition, overexpression of this gene during fetal development is thought to be the causal factor for transient neonatal diabetes mellitus (TNDM). Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding two different protein isoforms. The P1 downstream promoter of this gene is imprinted, with preferential expression from the paternal allele in many tissues. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.040873855).
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLAGL1NM_001317162.2 linkuse as main transcriptc.1132C>G p.Leu378Val missense_variant 8/8 ENST00000674357.1 NP_001304091.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLAGL1ENST00000674357.1 linkuse as main transcriptc.1132C>G p.Leu378Val missense_variant 8/8 NM_001317162.2 ENSP00000501459 P1Q9UM63-1

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152260
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000160
AC:
4
AN:
250386
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135530
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000198
AC:
29
AN:
1461886
Hom.:
0
Cov.:
32
AF XY:
0.0000179
AC XY:
13
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000252
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74390
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000416
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 14, 2023The c.1132C>G (p.L378V) alteration is located in exon 7 (coding exon 2) of the PLAGL1 gene. This alteration results from a C to G substitution at nucleotide position 1132, causing the leucine (L) at amino acid position 378 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
6.9
DANN
Benign
0.88
DEOGEN2
Benign
0.17
T;T;.;T;T;.;T;T;.;T;T;.;T;.
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.67
.;.;T;.;.;T;T;.;.;.;.;.;.;.
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.041
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.6
L;L;.;L;L;.;L;L;.;L;L;.;L;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.69
N;.;.;N;N;N;N;.;N;.;.;.;N;.
REVEL
Benign
0.021
Sift
Benign
0.32
T;.;.;T;T;T;T;.;T;.;.;.;T;.
Sift4G
Benign
0.15
T;.;D;T;T;T;T;.;T;T;.;.;T;T
Polyphen
0.034
B;B;.;B;B;.;B;B;.;B;B;.;B;.
Vest4
0.082
MutPred
0.19
Gain of catalytic residue at L378 (P = 0.0435);Gain of catalytic residue at L378 (P = 0.0435);.;Gain of catalytic residue at L378 (P = 0.0435);Gain of catalytic residue at L378 (P = 0.0435);.;Gain of catalytic residue at L378 (P = 0.0435);Gain of catalytic residue at L378 (P = 0.0435);.;Gain of catalytic residue at L378 (P = 0.0435);Gain of catalytic residue at L378 (P = 0.0435);.;Gain of catalytic residue at L378 (P = 0.0435);.;
MVP
0.28
MPC
0.38
ClinPred
0.025
T
GERP RS
-2.0
Varity_R
0.040
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201957325; hg19: chr6-144262821; API